Dr Reddys Laboratories Share Price Today | Stock Price & Dr Reddys Laboratories Share Screener

Track the current stock price of Dr Reddys Laboratories with an interactive chart. Analyse DRREDDY share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Dr Reddys Laboratories stock quote in one place.

The quote of ₹1,239.00 sits between the 52-week low of ₹1,135.60 and the 52-week high of ₹1,375.70, and the latest session moved -0.44% from the previous close.

Screen Dr Reddys Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DRREDDY shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE089A01031.

Classification

Identifiers and Leadership

Screen DRREDDY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹58,123, up from ₹49,427 in 2025.

Latest statistics put total assets at ₹58,123 and shareholder funds at ₹38,231, with a leverage ratio of 0.17.

Screen Dr Reddys Laboratories income statement and profit fundamentals. Analyze DRREDDY quarterly results. Dr Reddys Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹7,996 and net profit was ₹221, equal to earnings per unit of ₹2.65, at an operating margin of 5%.

In that period expenses were ₹7,164, interest cost ₹106 and tax ₹-22. The next period listed, 2026-Jun, shows revenue of ₹8,426 and net profit of ₹436.

Screen DRREDDY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹5,674, and net cash flow was an inflow of ₹78.

Over the same period, investing activities used ₹6,425 and financing activities provided ₹829.

See Dr Reddys Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Dr Reddys Laboratories promoter holding and ownership changes for DRREDDY on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 26.63%, foreign institutions 33.08%, domestic institutions 30.72% and the public 7.57%, spread across 449,665 shareholders.

The shareholder count was 449,665 in 2026-Mar, compared with 446,086 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Dr Reddys Laboratories. Dr Reddys Laboratories dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹8.00 per unit for 2026-March, a yield of 0.64%, compared with ₹8.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹8.00, ₹8.00 and ₹40.00 per unit.

See which indices include Dr Reddys Laboratories stock. Check DRREDDY index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 48 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE100.

Get Dr Reddys Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Dr Reddys Laboratories stock events that may affect DRREDDY share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 23, 2026, with a record date of October 23, 2026.

It is followed by Annual General Meeting dated July 23, 2026 and Quarterly Result Announcement dated July 22, 2026.

Screen DRREDDY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen DRREDDY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated October 16, 2026 and October 8, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 23, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.